These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 23566442

  • 1. Calcineurin inhibitors and Clostridium difficile infection in adult lung transplant recipients: the effect of cyclosporine versus tacrolimus.
    Lee JT, Whitson BA, Kelly RF, D'Cunha J, Dunitz JM, Hertz MI, Shumway SJ.
    J Surg Res; 2013 Sep; 184(1):599-604. PubMed ID: 23566442
    [Abstract] [Full Text] [Related]

  • 2. Clostridium difficile infection increases mortality risk in lung transplant recipients.
    Lee JT, Kelly RF, Hertz MI, Dunitz JM, Shumway SJ.
    J Heart Lung Transplant; 2013 Oct; 32(10):1020-6. PubMed ID: 23891145
    [Abstract] [Full Text] [Related]

  • 3. The rise of Clostridium difficile infection in lung transplant recipients in the modern era.
    Lee JT, Hertz MI, Dunitz JM, Kelly RF, D'Cunha J, Whitson BA, Shumway SJ.
    Clin Transplant; 2013 Oct; 27(2):303-10. PubMed ID: 23316931
    [Abstract] [Full Text] [Related]

  • 4. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
    Bozkaya G, Nart A, Uslu A, Onman T, Aykas A, Doğan M, Karaca B.
    Transplant Proc; 2008 Oct; 40(1):151-5. PubMed ID: 18261573
    [Abstract] [Full Text] [Related]

  • 5. Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function.
    Weir MR, Blahut S, Drachenburg C, Young C, Papademitriou J, Klassen DK, Cangro CB, Bartlett ST, Fink JC.
    Am J Nephrol; 2004 Oct; 24(4):379-86. PubMed ID: 15237243
    [Abstract] [Full Text] [Related]

  • 6. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D, Miquel R, Porrini E, Fernández A, González-Posada JM, Hortal L, Checa MD, Rodríguez A, García JJ, Rufino M, Torres A.
    Transplantation; 2007 Sep 27; 84(6):706-14. PubMed ID: 17893603
    [Abstract] [Full Text] [Related]

  • 7. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
    McDiarmid SV, Busuttil RW, Ascher NL, Burdick J, D'Alessandro AM, Esquivel C, Kalayoglu M, Klein AS, Marsh JW, Miller CM.
    Transplantation; 1995 Feb 27; 59(4):530-6. PubMed ID: 7533345
    [Abstract] [Full Text] [Related]

  • 8. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression.
    Hadley S, Samore MH, Lewis WD, Jenkins RL, Karchmer AW, Hammer SM.
    Transplantation; 1995 Mar 27; 59(6):851-9. PubMed ID: 7535482
    [Abstract] [Full Text] [Related]

  • 9. Incidence of malignant neoplasia after heart transplantation--a comparison between cyclosporine a and tacrolimus.
    Fuchs U, Klein S, Zittermann A, Ensminger SM, Schulz U, Gummert JF.
    Ann Transplant; 2014 Jun 23; 19():300-4. PubMed ID: 24953848
    [Abstract] [Full Text] [Related]

  • 10. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M, Pellegrini C, Martinelli L, Goggi C, Gavazzi A, Campana C, Arbustini E, Grossi P, Regazzi M, Ippoliti G, Vigano M.
    J Heart Lung Transplant; 1997 Oct 23; 16(10):1001-10. PubMed ID: 9361242
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 23; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 12. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P.
    Clin Transplant; 1995 Oct 23; 9(5):406-14. PubMed ID: 8541635
    [Abstract] [Full Text] [Related]

  • 13. [Application of tacrolimus and cyclosporine A in HBV-carrying renal transplant recipients].
    Liu XY, Yu LX, Fu SJ, Xu J, Du CF, Deng WF, Wang YB, Ye GR, Zhang YX.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul 23; 27(7):1090-2. PubMed ID: 17666359
    [Abstract] [Full Text] [Related]

  • 14. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF, Sirolimus CONVERT Trial Study Group.
    Transplantation; 2009 Jan 27; 87(2):233-42. PubMed ID: 19155978
    [Abstract] [Full Text] [Related]

  • 15. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
    Agarwal SK, Bhowmik D, Mahajan S, Bagchi S.
    Transpl Infect Dis; 2017 Feb 27; 19(1):. PubMed ID: 27775825
    [Abstract] [Full Text] [Related]

  • 16. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun 27; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 17. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
    DuBay D, Smith RJ, Qiu KG, Levy GA, Lilly L, Therapondos G.
    Liver Transpl; 2008 May 27; 14(5):651-9. PubMed ID: 18433069
    [Abstract] [Full Text] [Related]

  • 18. Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes.
    Burroughs TE, Lentine KL, Takemoto SK, Swindle J, Machnicki G, Hardinger K, Brennan DC, Irish WD, Schnitzler MA.
    Clin J Am Soc Nephrol; 2007 May 27; 2(3):517-23. PubMed ID: 17699459
    [Abstract] [Full Text] [Related]

  • 19. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
    Fairbanks KD, Eustace JA, Fine D, Thuluvath PJ.
    Liver Transpl; 2003 Oct 27; 9(10):1079-85. PubMed ID: 14526403
    [Abstract] [Full Text] [Related]

  • 20. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
    Yoshida EM, Lilly LB, Marotta PJ, Mason AL, Bilodeau M, Vaillancourt M.
    Ann Hepatol; 2013 Oct 27; 12(2):282-93. PubMed ID: 23396740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.